Medicine prices soar in Iran as US blockade and sanctions hit hard
Medication prices are soaring in Iran and some treatments have become hard to find, leaving patients and their families scrambling as a US blockade and stepped-up sanctions squeeze the country's pharmaceuticals industry.
Medication prices are rising in Iran, making some treatments difficult to find. This is due to a US blockade and increased sanctions affecting the country's pharmaceutical industry, according to France 24.
US President Donald Trump has denied reports that he offered sanctions relief to Iran in exchange for concessions on its nuclear program, as reported by CNBC and CNBC World.
The situation has left patients and their families struggling to access necessary treatments.
Brief written by urgent.news from France 24, Fortune, CNBC World, CNBC — 4 reports on this story. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- WTI drifts higher above $88.00 as Trump denies Iran sanctions relief fxstreet.com
- Trump denies offering Iran sanctions relief; Qatar pushes for peace talks cnbc.com
- ‘Americans need to wake up’: Iran calls on US voters to reject Trump ahead of elections hindustantimes.com
- Oil gains after Trump denies he is willing to ease Iran sanctions channelnewsasia.com
